Literature DB >> 17190953

Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.

T Miyamoto1, M Miyamoto, Y Inoue, Y Usui, K Suzuki, K Hirata.   

Abstract

Idiopathic REM sleep behavior disorder (RBD) may represent prodromal synucleinopathies. We report markedly reduced cardiac (123)I-metaiodobenzylguanidine uptake, consistent with the loss of sympathetic terminals, in idiopathic RBD. We also demonstrate that this reduction is of the same magnitude as that found in patients with Parkinson disease. The results are consistent with the hypothesis that idiopathic RBD in older patients is a forme fruste of Lewy body disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190953     DOI: 10.1212/01.wnl.0000249313.25627.2e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  68 in total

Review 1.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 2.  REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management.

Authors:  Lynn Marie Trotti
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

3.  Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study.

Authors:  Luigi Ferini-Strambi; Wolfgang Oertel; Yves Dauvilliers; Ronald B Postuma; Sara Marelli; Alex Iranzo; Isabelle Arnulf; Birgit Högl; Högl Birgit; Raffaele Manni; Tomoyuki Miyamoto; Maria-Livia Fantini; Monica Puligheddu; Poul Jennum; Karel Sonka; Joan Santamaria; Marco Zucconi; Paola M V Rancoita; Smeranda Leu-Semenescu; Birgit Frauscher; Michele Terzaghi; Masayuki Miyamoto; Marcus Unger; Karin Stiasny-Kolster; Alex Desautels; Christina Wolfson; Amélie Pelletier; Jacques Montplaisir
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

4.  Investigation of autonomic function in idiopathic REM sleep behavior disorder.

Authors:  Birgit Frauscher; Takashi Nomura; Susanne Duerr; Laura Ehrmann; Viola Gschliesser; Gregor K Wenning; Elisabeth Wolf; Yuichi Inoue; Birgit Högl; Werner Poewe
Journal:  J Neurol       Date:  2011-11-08       Impact factor: 4.849

Review 5.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

Review 6.  Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?

Authors:  Weidong Le; Jie Dong; Song Li; Amos D Korczyn
Journal:  Neurosci Bull       Date:  2017-09-02       Impact factor: 5.203

7.  Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study.

Authors:  Birgit Frauscher; Poul Jennum; Yo-El S Ju; Ronald B Postuma; Isabelle Arnulf; Valerie Cochen De Cock; Yves Dauvilliers; Maria L Fantini; Luigi Ferini-Strambi; David Gabelia; Alex Iranzo; Smaranda Leu-Semenescu; Thomas Mitterling; Masayuki Miyamoto; Tomoyuki Miyamoto; Jacques Y Montplaisir; Wolfgang Oertel; Amélie Pelletier; Paolo Prunetti; Monica Puligheddu; Joan Santamaria; Karel Sonka; Marcus Unger; Christina Wolfson; Marco Zucconi; Michele Terzaghi; Birgit Högl; Geert Mayer; Raffaele Manni
Journal:  Neurology       Date:  2014-02-19       Impact factor: 9.910

Review 8.  Sympathetic neuroimaging.

Authors:  David S Goldstein
Journal:  Handb Clin Neurol       Date:  2013

9.  Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control.

Authors:  Hee Young Shin; Eun Youn Joo; Seong Tae Kim; Hun-Jong Dhong; Jin Whan Cho
Journal:  Neurol Sci       Date:  2012-07-28       Impact factor: 3.307

Review 10.  REM sleep behaviour disorder in Parkinson's disease (Review).

Authors:  Ștefania Diaconu; Oana Falup-Pecurariu; Diana Țînț; Cristian Falup-Pecurariu
Journal:  Exp Ther Med       Date:  2021-05-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.